Form 4: MiNK Therapeutics Director Peter Behner Acquires Shares and Restricted Stock Units
SEC Form 4 Filing
Director Peter Behner acquired shares and restricted stock units in MiNK Therapeutics, Inc. on June 3, 2024.
Summary
- On June 3, 2024, Peter Behner, a director of MiNK Therapeutics, Inc., acquired 15,454 shares of common stock at a price of $0.99 per share.
- Following this transaction, Behner directly owns 90,481 shares of MiNK Therapeutics.
- Behner also received restricted stock units (RSUs) in lieu of cash retainers for board and committee compensation, with each RSU representing the right to receive one share of common stock.
- The RSUs will vest one month from the grant date.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's stock purchase suggests confidence, but it's a routine transaction.
Positives
- A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of transaction: Peter Behner acquired common stock and RSUs. |
| 06/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.